Trial NCT04422210

View at ClinicalTrials.gov 
Org. Study IDs: GO41864
Secondary IDs: 2019-004487-22

Last trial update was posted on 2021-11-08

MeSH Interventions

Atezolizumab Carboplatin Etoposide Venetoclax

MeSH Conditions

Lung Neoplasms Small Cell Lung Carcinoma

Other Conditions

Small Cell Lung Cancer

Stopping Reasons

Decision to discontinue the study based on broader development and strategic prioritisation. The Sponsor concludes there is no benefit-risk impact on the GO41864 study.

Limitations And Caveats

The study was terminated by the Sponsor. Only 2 participants were enrolled in this study. Based on the low enrolment number, no data is reported here in order to protect and maintain participant privacy/confidentiality.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID